Literature DB >> 3025890

Passive protection across subgroups of alphaviruses by hyperimmune non-cross-neutralizing anti-Sindbis serum.

C J Wust, R Crombie, A Brown.   

Abstract

Extended hyperimmunization of rabbits with Sindbis (SIN) or Semliki Forest (SF) viruses causes the production of antisera that are cross-reactive with virus-infected cells in antibody-dependent, complement-mediated cytotoxicity assays but that do not cross-neutralize viruses in vitro. C3H/HeJ mice given gamma globulin fractionated from the extended hyperimmune antiserum against SIN, but not control sera, were protected from challenge by 100 LD50 of SF, a virus which is in a different subgroup than SIN. All mice survived if the gamma globulin was given 24 hr before challenge virus and partial protection occurred if the globulin was given 24 hr after the virus. Cobra venom factor treatment of normal C3H mice challenged with SF did not reduce the protection, suggesting that complement was not involved. Methyl palmitate (40 mg/mouse) given before gamma globulin and virus challenge suppressed macrophage activity and reduced the level of protection 23% in females and 70% in males. Silica treatment (3 mg/mouse) reduced the protection equally in both males and females by 92%. In vitro experiments were done to test if it were possible that cross-antibody-dependent cellular cytotoxicity (ADCC) could account for the passive cross-protection observed in this system. Cross-ADCC could be demonstrated in vitro at high dilutions of antiserum (1:25,600). On the basis of the in vitro and in vivo results presented, we suggest that cross-ADCC against SF-infected target cells is one of the likely mechanisms to explain the passive cross-protection observed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3025890     DOI: 10.3181/00379727-184-42446

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  15 in total

1.  Monoclonal Antibodies as Prophylactic and Therapeutic Agents Against Chikungunya Virus.

Authors:  April M Clayton
Journal:  J Infect Dis       Date:  2016-12-15       Impact factor: 5.226

2.  Infection of a human leukemia K-562 cell line with Semliki Forest virus.

Authors:  D D King; B Brady; D Dodd; C J Wust; A Brown
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

3.  Optimal therapeutic activity of monoclonal antibodies against chikungunya virus requires Fc-FcγR interaction on monocytes.

Authors:  Julie M Fox; Vicky Roy; Bronwyn M Gunn; Ling Huang; Melissa A Edeling; Matthias Mack; Daved H Fremont; Benjamin J Doranz; Syd Johnson; Galit Alter; Michael S Diamond
Journal:  Sci Immunol       Date:  2019-02-22

4.  Chikungunya virus arthritis in adult wild-type mice.

Authors:  Joy Gardner; Itaru Anraku; Thuy T Le; Thibaut Larcher; Lee Major; Pierre Roques; Wayne A Schroder; Stephen Higgs; Andreas Suhrbier
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

Review 5.  The alphaviruses: gene expression, replication, and evolution.

Authors:  J H Strauss; E G Strauss
Journal:  Microbiol Rev       Date:  1994-09

6.  A chimeric vesiculo/alphavirus is an effective alphavirus vaccine.

Authors:  Anasuya Chattopadhyay; Eryu Wang; Robert Seymour; Scott C Weaver; John K Rose
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

7.  Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress.

Authors:  Julie M Fox; Feng Long; Melissa A Edeling; Hueylie Lin; Mareike K S van Duijl-Richter; Rachel H Fong; Kristen M Kahle; Jolanda M Smit; Jing Jin; Graham Simmons; Benjamin J Doranz; James E Crowe; Daved H Fremont; Michael G Rossmann; Michael S Diamond
Journal:  Cell       Date:  2015-11-06       Impact factor: 41.582

8.  Isolation and characterisation of a human-like antibody fragment (scFv) that inactivates VEEV in vitro and in vivo.

Authors:  Torsten Rülker; Luzie Voß; Philippe Thullier; Lyn M O' Brien; Thibaut Pelat; Stuart D Perkins; Claudia Langermann; Thomas Schirrmann; Stefan Dübel; Hans-Jürgen Marschall; Michael Hust; Birgit Hülseweh
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

9.  Broad and long-lasting immune protection against various Chikungunya genotypes demonstrated by participants in a cross-sectional study in a Cambodian rural community.

Authors:  Heidi Auerswald; Camille Boussioux; Saraden In; Sokthearom Mao; Sivuth Ong; Rekol Huy; Rithea Leang; Malen Chan; Veasna Duong; Sowath Ly; Arnaud Tarantola; Philippe Dussart
Journal:  Emerg Microbes Infect       Date:  2018-02-07       Impact factor: 7.163

10.  Protective antibodies against Eastern equine encephalitis virus bind to epitopes in domains A and B of the E2 glycoprotein.

Authors:  Arthur S Kim; S Kyle Austin; Christina L Gardner; Adam Zuiani; Douglas S Reed; Derek W Trobaugh; Chengqun Sun; Katherine Basore; Lauren E Williamson; James E Crowe; Mark K Slifka; Daved H Fremont; William B Klimstra; Michael S Diamond
Journal:  Nat Microbiol       Date:  2018-11-19       Impact factor: 17.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.